trending Market Intelligence /marketintelligence/en/news-insights/trending/puz7hkz3zaef4uhpdexnmw2 content esgSubNav
In This List

Xtant Medical regains compliance with NYSE American exchange listing rules

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Xtant Medical regains compliance with NYSE American exchange listing rules

Xtant Medical Holdings Inc. said it resolved a previous issue with stockholders' equity deficiency and regained compliance with NYSE American exchange's continuing listing standards.

The Belgrade, Mont.-based regenerative medicine developer reported a positive stockholders' equity of approximately $47.4 million as of Feb. 15, 2018.

This reflects a restructuring agreement involving an exchange of about $70.2 million worth of debt for shares in the company with ROS Acquisition Offshore LP and OrbiMed Royalty Opportunities II LP.

The company had also exchanged debt in the principal amount of $1.6 million for 2,275,745 of its common shares and sold another 945,819 common shares in a private placement.